# Vertical Longevity Pharmaceuticals, Inc. — Form C (Regulation Crowdfunding)

Vertical Longevity Pharmaceuticals, Inc. of Irvine, CA filed a Form C (Regulation Crowdfunding) with the SEC on 2025-10-10. Target raise $10K, up to $500K. Offered through NetCapital Funding Portal Inc..

## Offering

- Filed: 2025-10-10
- Form: C
- Accession: 0001669191-25-000512
- Target amount: $10K
- Maximum amount: $500K
- Security type: Common Stock
- Securities offered: 10,310
- Price: $0.9700
- Deadline: 2026-01-16
- Funding portal / intermediary: NetCapital Funding Portal Inc.
- Intermediary file number: 007-00035
- Intermediary CRD: 283596

## Issuer

- CIK: 0002087846
- Website: https://vertical-longevity-pharma.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2025-03-21
- Address: 17 Rincon, Irvine, CA, 92620
- Employees: 2

## People (5)

| Name | Role | Location |
| --- | --- | --- |
| David Scieszka | Board Member | Irvine, CA |
| David Scieszka | President | Irvine, CA |
| David Scieszka | Principal Accounting Officer | Irvine, CA |
| David Scieszka | Principal Executive Officer | Irvine, CA |
| David Scieszka | Principal Financial Officer | Irvine, CA |

## Reg CF filing history (3)

| Filed | Form | Target | Max |
| --- | --- | --- | --- |
| [2026-04-27](https://search.stillhousedata.com/formc/0002087846-26-000002) | C-TR | — | — |
| [2026-03-30](https://search.stillhousedata.com/formc/0002087846-26-000001) | C-AR | — | — |

## More

- [CIK 2087846 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2087846&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formc/0001669191-25-000512.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.
